DavidMichaelBaratzMD

Pulmonology • Phoenix, AZ

Critical Care Medicine, Pulmonary Vascular Medicine, Sleep Medicine

Pulmonary Associates

Join to view full profile

Dr. Baratz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Baratz's full profile

Already have an account?

Office
3811 E Bell Rd
Ste 107
Phoenix, AZ 85032
Phone+1 602-340-1689

Fax+1 602-340-1853

Education & Training

Cedars-Sinai Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1991
University of California (Irvine)Residency, Internal Medicine, 1985 - 1988
University of Arizona College of MedicineClass of 1985

Certifications & Licensure

AZ State Medical License 1991 - 2025
CA State Medical License 1986 - 2010
National Board of Physicians and Surgeons Pulmonary Disease
National Board of Physicians and Surgeons Sleep Medicine

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program Start of enrollment: 2011 Jun 01
Completed
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary Fibrosis Start of enrollment: 2016 May 26
Completed
Phase 2
Study to Assess the Intrapulmonary Pharmacokinetics of SPR859 by Comparing the Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) Concentrations Following the Oral Administration of Five Doses of SPR994 in Healthy, Nonsmoking Volunteers Start of enrollment: 2020 Dec 07
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

3 citations
A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis.
Hiroyuki Doi, Jun Atsumi, David Baratz, Yohei Miyamoto
Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2023-12-01
2 citations
Operating Characteristics of Pulmonary Capillary Wedge Pressure for Pulmonary Arterial Hypertension
Robert Raschke, Richard Gerkin, Steven C. Curry, David M. Baratz
Chest. 2010-03-01
107 citations
Effect of nasal continuous positive airway pressure on cardiac output and oxygen delivery in patients with congestive heart failure.
David M. Baratz, Philip R. Westbrook, Prediman K. Shah, Zab Mohsenifar
Chest. 1992-11-01